HighPoint Advisor Group’s Boston Scientific BSX Stock Holding History

HighPoint Advisor Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365K	Buy	8,551 +1,170	+16%	+$63.5K	0.01%	533
2026 Q1	$463K	Sell	7,381 -24,854	-77%	-$1.99M	0.02%	436
2025 Q4	$3.07M	Sell	32,235 -21,208	-40%	-$2.08M	0.07%	248
2025 Q3	$5.22M	Buy	53,443 +2,495	+5%	+$258K	0.25%	69
2025 Q2	$5.47M	Buy	50,948 +30,394	+148%	+$3.08M	0.29%	60
2025 Q1	$2.11M	Buy	20,554 +125	+0.6%	+$12.6K	0.12%	137
2024 Q4	$2.05M	Buy	20,429 +1,683	+9%	+$148K	0.11%	148
2024 Q3	$1.57M	Sell	18,746 -7,052	-27%	-$556K	0.09%	172
2024 Q2	$1.91M	Buy	25,798 +13,957	+118%	+$1.02M	0.11%	143
2024 Q1	$862K	Buy	11,841 +3,720	+46%	+$239K	0.06%	242
2023 Q4	$546K	Buy	+8,121	New	+$433K	0.04%	336
2022 Q2	$207K	Buy	+5,493	New	+$224K	0.02%	485
2021 Q3	$221K	Sell	5,094 -712	-12%	-$31.5K	0.02%	488
2021 Q2	$248K	Buy	+5,806	New	+$244K	0.03%	443

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HighPoint Advisor Group's BSX Position: Q2 2026 in Review

HighPoint Advisor Group increased its Boston Scientific (BSX) stake by 16% in Q2 2026, buying an estimated $63.5K and bringing the position to 8,551 shares worth $365K. The position accounts for 0.01% of the portfolio, ranked #533.

HighPoint Advisor Group first reported a position in BSX in Q2 2021 and has held it in 14 quarters since. The position peaked at $5.47M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

HighPoint Advisor Group held 8,551 shares of Boston Scientific worth $365K as of Q2 2026.
HighPoint Advisor Group bought 1,170 Boston Scientific shares in Q2 2026, an estimated $63.5K.
Boston Scientific made up 0.01% of HighPoint Advisor Group's portfolio in Q2 2026, its #533 holding.
HighPoint Advisor Group first reported a position in Boston Scientific in Q2 2021 and has held it in 14 quarters since.
HighPoint Advisor Group's Boston Scientific position peaked at $5.47M in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.